Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis

Published:2021-09 Issue:9 Volume:19 Page:1925-1932.e1
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Singal Amit G.,Patibandla Sruthi,Obi Joseph,Fullington Hannah,Parikh Neehar D.,Yopp Adam C.,Marrero Jorge A.

Funder

Agency for Healthcare Research and Quality

National Cancer Institute

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference34 articles.

1. Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012;White;Gastroenterology,2017

2. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma;Yang;Clin Gastroenterol Hepatol,2011

3. Contemporary epidemiology of chronic liver disease and cirrhosis;Moon;Clin Gastroenterol Hepatol,2020

4. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases;Marrero;Hepatology,2018

5. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma;J Hepatol,2018

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of non-contrast abbreviated MRI and ultrasound as surveillance modalities for HCC;Journal of Hepatology;2024-09

2. Screening for Hepatocellular Carcinoma and Survival in Patients With Cirrhosis After Hepatitis C Virus Cure;JAMA Network Open;2024-07-10

3. HES V2.0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United States;Hepatology;2024-06-19

4. Cost-Effectiveness of a Biomarker-Based Screening Strategy for Hepatocellular Carcinoma in Patients with Cirrhosis;Liver Cancer;2024-06-18

5. Effectiveness of mailed outreach and patient navigation to promote HCC screening process completion: a multicentre pragmatic randomised clinical trial;Gut;2024-06-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3